Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FormidableMD vs Vea Health

FormidableMD
Graded #74

Higher grade

vs+17.900000000000006
Vea Health
Graded #451

Lower grade

The verdict

FormidableMD takes it — 72.9/100 to 55/100.

FormidableMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormidableMD is a physician-led, cash-pay telehealth practice based in Florida offering GLP-1 weight-loss treatment — semaglutide and tirzepatide in both FDA-approved and compounded forms, plus oral options…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFormidableMD +10
55
45
Dose & formulationFormidableMD +27
78
51
Clinical oversightFormidableMD +22
88
66
Labs & monitoringFormidableMD +31
83
52
FulfillmentFormidableMD +4
72
68
Contract termsFormidableMD +6
61
55
FormidableMD · left barVea Health · right bar

The numbers

MetricFormidableMDVea Health
WeighScore72.9/10055/100
GradeCC
Scorecard rank#74#451
Semaglutide$169/mo (1 mg dose, compounded)Not disclosed
Tirzepatide$199/mo (10 mg dose, compounded)Not disclosed
Coverage1 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesYes
FormidableMD

Graded #74 · C

Strengths

  • Transparent, published dose-by-dose pricing for semaglutide ($169-$269/mo) and tirzepatide ($199-$319/mo) with no membership or commitment
  • Offers both FDA-approved and compounded GLP-1s (plus oral options) from 503A pharmacies, with a real provider at every visit
  • Boutique physician-led model bundling labs, peptides, HRT/TRT and urgent care; FSA/HSA eligible

Where it loses points

  • Florida-focused telehealth — availability outside FL is not advertised, so out-of-state access is uncertain
  • Medication cost is on top of a $199 initial consultation and $99 follow-up visits (pay-per-visit, not an all-in monthly price)
  • The 503A compounding pharmacy partner is not named on the site
Vea Health

Graded #451 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard